Annals of Pharmacotherapy

Published by: Sage Publications  

People

  1. Daley
    Daley
  2. Kabel
    Kabel
  3. Kumar
    Kumar
  4. Lesokhin
    Lesokhin

Groups

  1. Clinical Pharmacy Specialists (3)
  2. Center for Hematologic Malignancies (2)
  3. Department of Medicine (2)
  4. Hematologic Malignancies, Division of (2)
  5. Hematologic Malignancies Research (1)
  6. Lymphoma (1)
  7. Myeloma (1)
Search Within
Formats
  1. Journal Article (6)
  2. Review (3)
Groups
  1. Clinical Pharmacy Specialists (3)
  2. Center for Hematologic Malignancies (2)
  3. Department of Medicine (2)
  4. Hematologic Malignancies, Division of (2)
  5. Hematologic Malignancies Research (1)
  6. Lymphoma (1)

More Groups

People
  1. Troy Horvat (4)
  2. Amber King (3)
  3. Ryan Daley (3)
  4. Tim Peterson (3)
  5. Adebayo Ogunniyi (2)
  6. Jennifer Orozco (2)

More People

Years
  1. 2020 (2)
  2. 2019 (1)
  3. 2018 (1)
  4. 2017 (1)
  5. 2016 (1)
  6. 2015 (2)

More Years

Publishers
  1. Sage Publications (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Management of mantle cell lymphoma in the era of novel oral agents
    Review

    Buege, M. J.; Kumar, A.; Dixon, B. N.; Tang, L. A.; Pak, T.; Orozco, J.; Peterson, T. J.; Maples, K. T.
    Annals of Pharmacotherapy (2020)

    Fulltext@MSK | Save
  • Selinexor: A first-in-class nuclear export inhibitor for management of multiply relapsed multiple myeloma
    Review

    Peterson, T. J.; Orozco, J.; Buege, M.
    Annals of Pharmacotherapy (2020)

    Fulltext@MSK | Save
  • No loose ends: A review of the pharmacotherapy of hairy cell and hairy cell leukemia variant
    Review

    King, A. C.; Kabel, C. C.; Pappacena, J. J.; Stump, S. E.; Daley, R. J.
    Annals of Pharmacotherapy (2019)

    Fulltext@MSK | Save
  • The ABCs of immunotherapy for adult patients with B-cell acute lymphoblastic leukemia
    Journal Article

    Horvat, T. Z.; Seddon, A. N.; Ogunniyi, A.; King, A. C.; Buie, L. W.; Daley, R. J.
    Annals of Pharmacotherapy (2018)

    Fulltext@MSK | Save
  • Venetoclax: A first-in-class oral BCL-2 inhibitor for the management of lymphoid malignancies
    Journal Article

    King, A. C.; Peterson, T. J.; Horvat, T. Z.; Rodriguez, M.; Tang, L. A.
    Annals of Pharmacotherapy (2017)

    Fulltext@MSK | Save
  • Immunotherapy: A new approach to treating multiple myeloma with daratumumab and elotuzumab
    Journal Article

    Afifi, S.; Michael, A.; Lesokhin, A.
    Annals of Pharmacotherapy (2016)

    Fulltext@MSK | Save
  • Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncology
    Journal Article

    Barbee, M. S.; Ogunniyi, A.; Horvat, T. Z.; Dang, T. O.
    Annals of Pharmacotherapy (2015)

    Fulltext@MSK | Save
  • Blinatumomab: A first-in-class bispecific T-cell engager for precursor B-cell acute lymphoblastic leukemia
    Journal Article

    Buie, L. W.; Pecoraro, J. J.; Horvat, T. Z.; Daley, R. J.
    Annals of Pharmacotherapy (2015)

    Fulltext@MSK | Save
  • Gastroenteropancreatic neuroendocrine tumors: Update on therapeutics
    Journal Article

    Ganetsky, A.; Bhatt, V.
    Annals of Pharmacotherapy (2012)

    Fulltext@MSK | Save

    • Annals of Pharmacotherapy – authorized name for:

    Name ISSN / ISBN Publisher
    Annals of Pharmacotherapy 1060-0280 Sage Publications
    Annals of Pharmacotherapy 1060-0280 Sage Publications, Inc.
    Annals of Pharmacotherapy 10600280 The Author(s) 2019
    Annals of Pharmacotherapy 1060-0280 Sage Publications
    Annals of Pharmacotherapy 10600280 Annals of Pharmacotherapy
    Annals of Pharmacotherapy 1060-0280 Sage Publications
    Annals of Pharmacotherapy 1060-0280 Sage Publications
    Annals of Pharmacotherapy 10600280 2017, © The Author(s) 2017
    Annals of Pharmacotherapy 1060-0280 Sage Publications
    Annals of Pharmacotherapy 1060-0280 Sage Publications
    Annals of Pharmacotherapy 1060-0280 Unknown